Innovative Technology for a Healthy Future

Are You Concerned About the Threat Antibiotic-Resistant Bacteria Pose?

You are not alone. We shared the same concerns, which led us to establish Lysando in 2009.
We are a Liechtenstein-based company, with a research facility in Regensburg, Germany, with a primary objective of enhancing the lives of millions through pioneering medical research and development.

Through the development of Artilysin^®, we have pioneered a revolutionary technology that safeguards individuals from dangerous bacterial infections. Our innovative technology plays a crucial role in curbing the dissemination of antibiotic-resistant bacteria (AMR) and offers everyone the opportunity to lead a healthier and safer life.

We have achieved significant milestones and remain resolute in our commitment to continue until the fear of bacterial infections becomes a thing of the past.

What Is Artilysin^®?

What was once a mere idea in 2009 has now evolved into a groundbreaking technology that revolutionizes the way we combat harmful bacteria, including those that are antibiotic-resistant. Artilysin^® serves as a comprehensive collection of antimicrobial proteins, specifically engineered to effectively target any bacterial species, thereby maximizing its potential benefits.

How Artilysin^® Works

Artilysin® rapidly destroys both Gram-positive and Gram-negative bacteria. In the case of Gram-negative bacteria, Artilysin® penetrates the outer membrane, causing the bacterial cell wall to become unstable. Due to this destabilization, the cell wall can no longer withstand the high osmotic pressure, leading to the bursting of the bacterial cell.

The Advantages Are Clear

Artilysin^® rapidly and efficiently eliminates bacteria while preserving the microbiome. Bacterial resistance formation has not been observed with Artilysin^®.

Our Technology: Bringing Balance to the System

Around 150 years ago, Louis Pasteur hypothesized that bacterial infections cause disease. His theory suggested that the key to a healthy life lay in maintaining a germ-free environment both inside the body and elsewhere. This belief gave rise to the widespread use of antibiotics and the many adverts for mouthwashes and cleaning products that claim to eliminate 99.9% of bacteria.

In recent decades, our understanding of bacteria has changed dramatically. We now know that instead of being germ-free, parts of our body, including the lungs, bladder, nose and ears, are in fact inhabited by bacteria.

These commensal bacteria play a pivotal role in preventing the spread of harmful pathogens.

Commensal bacteria frequently work in harmony with our immune system, playing a significant role in supporting the immune response against pathogens through their various interactions and influences. A perfect example of this occurs on the skin, where the skin environment promotes the growth of specific bacterial species, which in turn provide essential substances such as fatty acids and vitamins.

Striving for sterility has proven to be detrimental to our health as it weakens the beneficial role of commensal bacteria in the immune defense.

Artilysin^® and the Microbiome

Most infections do not arise solely from bacterial colonization; they occur because of an imbalance among bacterial species

Depending on the disease, Artilysin® does not strive to eliminate all bacteria, but rather it aims to restore the microbial balance by suppressing pathogens. Preserving the immune function of our microbiome is crucial.

Success Stories – Transforming lives through Artilysin®

Ältere Frau mit grauen Haaren mit ihrer Hand auf ihrem Ehemann.

Dancing With Joy

Dancing with her husband used to bring immense joy to Christa’s life. But that all changed when the 78-year-old began suffering from atopic dermatitis (eczema), which was particularly severe on her hands. Despite trying traditional treatments, Christa’s pain intensified over the years, impacting her daily life and causing symptoms such as sensitivity to touch, flaky skin, thickened leathery patches, and persistent eczema.

When Christa’s husband discovered Lysando, he contacted us promptly, sharing details of Christa’s symptoms and the devastating impact her condition had. We were thrilled to be able to offer Christa some hope.

Working in collaboration with Christa’s physician, the Lysando Team facilitated access to an Artilysin® prototype spray. In just 13 days, there was a significant improvement in Christa’s symptoms, with her itchiness, redness, and eczema all beginning to subside.

At the end of her treatment, Christa was not only free from the pain and distress that had blighted her life for so long, but she had also regained control over her hands. She could dance with her beloved husband once again.

"Two weeks after the treatment, my wife is physically and mentally better than she has been for 3 years!"

Christas Husband Dieter Ostertag

A New Chapter

Mrs. S. had suffered with acne since she was a teenager, experiencing large, painful spots on her face, particularly concentrated around her chin and jawline, as well as on her shoulders. Living with acne had taken its toll on her mental health and self-esteem.

In her quest for relief, Mrs. S. explored various acne treatments but none of them worked. The discontinuation of birth control only exacerbated her acne symptoms further. In her desperation, Mrs. S. contacted Lysando.

After just seven weeks of Artilysin®, Mrs. S. experienced a significant reduction in inflammation and erythema. Her spots had shrunk, and she had tolerated the Artilysin® treatment well. She did not report any side-effects.

Artilysin® is the only treatment that has worked against Mrs. S.’s acne. Her life has been transformed because of it.

"After years of battling stubborn acne and trying every treatment available, I had the incredible opportunity to try this revolutionary solution. My skin has transformed beyond expectations."

Mrs. S.

Sensitive Content
This photo contains sensitive content and shows open wounds that some people may find disturbing.

Healing Infected Wounds

Artilysin® has helped numerous people suffering from infected wounds. Mr. D. included.

He had suffered from an infected wound for 25 weeks. The wound hosted the bacterial species E. corrodens and E. coli, and prior to the application of Artilysin®, multiple attempts to heal the wound using various conventional therapies had been unsuccessful.

Over a three-week period, Mr. D.’s physician administered the Medolysin® wound spray – our in-market product containing a specifically formulated Artilysin® – in conjunction with the simultaneous use of Vliwaktiv® absorbent dressing pads.

The treatment produced remarkable results: the size of Mr. D.’s wound had reduced by 82% and most notably, he reported being completely pain-free at the end of his treatment.

Be Part of the Solution

We firmly believe that everyone should have access to safe and effective healthcare solutions, and are confident in the transformative potential of this groundbreaking technology to safeguard and enhance people’s well-being.

If you’re interested in learning more or partnering with us, subscribe to our newsletter or get in touch via our contact form

NAME

SURNAME

I would like to receive your newsletter and accept the privacy policy.

We use Brevo as our marketing platform. By completing and submitting the form, you acknowledge that the information you provide will be sent to Brevo for processing in accordance with the Terms of Use.